Unruptured Intracranial Aneurysm Treatment Market

Unruptured Intracranial Aneurysm Treatment Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 200

Unruptured Intracranial Aneurysm Treatment Market

To learn more about this report, request a free sample copy

Unruptured Intracranial Aneurysm Treatment Market Overview

The report is titled as ‘Unruptured Intracranial Aneurysm Treatment Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the unruptured intracranial aneurysm treatment market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Unruptured intracranial aneurysm treatment market is expected to grow with significant rate in the near future.

The global unruptured intracranial aneurysm treatment market in 2020 is estimated for more than US$ 1,027.1 Mn and expected to reach a value of US$ 1,937.4 Mn by 2028 with a significant CAGR of 8.3%.

Unruptured Intracranial Aneurysm Treatment Market Dynamics

Unruptured intracranial aneurysm is the leading cause of hemorrhagic stroke which can be so severe that it can lead to coma or even death which is the major driving force of the global unruptured intracranial aneurysm treatment market. For instance, according to Angiology Journal, in United Kingdom 10% to 15% of patients with unruptured intracranial aneurysm die before reaching the hospital.

Further, presence of unruptured intracranial aneurysm in the family history is also another factor responsible for the growth of the global unruptured intracranial aneurysm treatment market. Moreover, increasing healthcare funding by government bodies, is also likely to boost the target market. Additionally, high occurrence of high blood pressure in the individuals will also flourish the target market. Further, advancement in surgical techniques and development of new drugs will also fuel the global unruptured intracranial aneurysm treatment market.

Unruptured Intracranial Aneurysm Treatment Market Segmentation

Unruptured Intracranial Aneurysm Treatment Market Segmentation

By Treatment Method 

•    Surpass Streamline

•    Other 

By Region 

•    North America

•    Europe

•    Asia Pacific

•    Latin America

•    Middle East

•    Africa

Unruptured Intracranial Aneurysm Treatment Market Pipeline Treatment Overview

The global unruptured intracranial aneurysm treatment market has a drug and a flow diverter in a pipeline which are undergoing clinical trials Aspirin and Surpass Streamline Flow Diverter. For the treatment of pain, inflammation and fever, Aspirin is considered as the most common drug which is used around the globe. Some healthcare experts recommend Aspirin to their patients for the prevention of heart attacks and strokes. Its anti-inflammatory properties may be beneficial for patients with unruptured intracranial aneurysm.

The study was designed in 2018, to test whether there is a measurable reduction in inflammation in walls of unruptured intracranial aneurysm with the use of aspirin which is under the phase 2 clinical trial. Surpass Streamline Flow Diverter is used for the large and giant posterior communicating unruptured intracranial aneurysm as they are located in a very challenging area of the body. The device has gained pre market FDA approval for the treatment of unruptured intracranial aneurysm.

Unruptured Intracranial Aneurysm Treatment Market Competitive Landscape

Some of the key participating players in global unruptured intracranial aneurysm treatment market is Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, and Spiegelberg GmbH.

Regional Segmentation

On the basis of region, the unruptured intracranial aneurysm treatment market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Reports & Insights Overview on Unruptured Intracranial Aneurysm Treatment Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Unruptured Intracranial Aneurysm Treatment market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Unruptured Intracranial Aneurysm Treatment

•    Advantages of Unruptured Intracranial Aneurysm Treatment

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


Summarized Info Details
Base Year: 2020 Forecast Period: 2021-2028
Key Geographies:
  • North America, Latin America, Europe, Asia Pacific, Middle East and Africa
Market Segmentation:
  • Treatment method and region are the segments which are covered in market report
Key Players:

Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, and Spiegelberg GmbH and among others,

Key Dynamics:
  • Increase in prevalence for high blood pressure in the individuals, and advancement in surgical techniques and development of new drugs are the key factors driving the growth of market
Market Size: US$ 1,027.1 Mn CAGR: 8.3%

To learn more about this report, request a free sample copy


1.    Global Unruptured Intracranial Aneurysm Treatment Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Unruptured Intracranial Aneurysm Treatment Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Unruptured Intracranial Aneurysm Treatment Market Snapshot

2.4.    Global Unruptured Intracranial Aneurysm Treatment Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Unruptured Intracranial Aneurysm Treatment Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Treatment Method

3.1.2.    BPS Analysis, By Treatment Method

3.2.    Market Revenue (US$Mn) Forecast, By Treatment Method

3.2.1.    Surpass Streamline

3.2.2.    Other

3.3.    Global Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index, By Treatment Method

4.    Global Unruptured Intracranial Aneurysm Treatment Market, By Region

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Region

4.1.2.    BPS Analysis, By Region

4.2.    Market Revenue (US$Mn) Forecast, By Region

4.2.1.    North America

4.2.2.    Latin America

4.2.3.    Europe

4.2.4.    Asia Pacific

4.2.5.    Middle East

4.2.6.    Africa

4.3.    Global Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index, By Region

5.    North America Unruptured Intracranial Aneurysm Treatment Market Analysis and Forecast, 2020–2028

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Country

5.1.2.    BPS Analysis, By Country

5.2.    Market Revenue (US$Mn) Forecast, By Country

5.2.1.    U.S. Unruptured Intracranial Aneurysm Treatment Market

5.2.2.    Canada Unruptured Intracranial Aneurysm Treatment Market

5.3.    North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method

5.3.1.    Surpass Streamline

5.3.2.    Other

5.4.    North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index

5.4.1.    By Country

5.4.2.    By Treatment Method

6.    Latin America Unruptured Intracranial Aneurysm Treatment Market Analysis and Forecast, 2019–2027

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market (US$Mn) Forecast, By Country

6.2.1.    Brazil Unruptured Intracranial Aneurysm Treatment Market

6.2.2.    Mexico Unruptured Intracranial Aneurysm Treatment Market

6.2.3.    Argentina Unruptured Intracranial Aneurysm Treatment Market

6.2.4.    Rest of Latin America Unruptured Intracranial Aneurysm Treatment Market

6.3.    North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method

6.3.1.    Surpass Streamline

6.3.2.    Other

6.4.    North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index

6.4.1.    By Country

6.4.2.    By Treatment Method

7.    Europe Unruptured Intracranial Aneurysm Treatment Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) Forecast, By Country

7.2.1.    U.K. Unruptured Intracranial Aneurysm Treatment Market

7.2.2.    Germany Unruptured Intracranial Aneurysm Treatment Market

7.2.3.    Italy Unruptured Intracranial Aneurysm Treatment Market

7.2.4.    France Unruptured Intracranial Aneurysm Treatment Market

7.2.5.    Spain Unruptured Intracranial Aneurysm Treatment Market

7.2.6.    Russia Unruptured Intracranial Aneurysm Treatment Market

7.2.7.    Poland Unruptured Intracranial Aneurysm Treatment Market

7.2.8.    BENELUX Unruptured Intracranial Aneurysm Treatment Market

7.2.9.    NORDIC Unruptured Intracranial Aneurysm Treatment Market

7.2.10.    Rest of Europe Unruptured Intracranial Aneurysm Treatment Market

7.3.    North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method

7.3.1.    Surpass Streamline

7.3.2.    Other

7.4.    North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index

7.4.1.    By Country

7.4.2.    By Treatment Method

8.    Asia Pacific Unruptured Intracranial Aneurysm Treatment Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    China Unruptured Intracranial Aneurysm Treatment Market

8.2.2.    India Unruptured Intracranial Aneurysm Treatment Market

8.2.3.    Japan Unruptured Intracranial Aneurysm Treatment Market

8.2.4.    Australia and New Zealand Unruptured Intracranial Aneurysm Treatment Market

8.2.5.    South Korea Unruptured Intracranial Aneurysm Treatment Market

8.2.6.    ASEAN Unruptured Intracranial Aneurysm Treatment Market

8.2.7.    Rest of Asia Pacific Unruptured Intracranial Aneurysm Treatment Market

8.3.    North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method

8.3.1.    Surpass Streamline

8.3.2.    Other

8.4.    North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index

8.4.1.    By Country

8.4.2.    By Treatment Method

9.    Middle East Unruptured Intracranial Aneurysm Treatment Market, By Region

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    GCC Countries Unruptured Intracranial Aneurysm Treatment Market

9.2.2.    Israel Unruptured Intracranial Aneurysm Treatment Market

9.2.3.    Oman Unruptured Intracranial Aneurysm Treatment Market

9.2.4.    Rest of Middle East Unruptured Intracranial Aneurysm Treatment Market

9.3.    North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method

9.3.1.    Surpass Streamline

9.3.2.    Other

9.4.    North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index

9.4.1.    By Country

9.4.2.    By Treatment Method

10.    Africa Unruptured Intracranial Aneurysm Treatment Market, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    South Africa Unruptured Intracranial Aneurysm Treatment Market

10.2.2.    Egypt Unruptured Intracranial Aneurysm Treatment Market

10.2.3.    North Africa Unruptured Intracranial Aneurysm Treatment Market

10.2.4.    Rest of Africa Unruptured Intracranial Aneurysm Treatment Market

10.3.    North America Unruptured Intracranial Aneurysm Treatment Market, By Treatment Method

10.3.1.    Surpass Streamline

10.3.2.    Other

10.4.    North America Unruptured Intracranial Aneurysm Treatment Market Attractiveness Index

10.4.1.    By Country

10.4.2.    By Treatment Method

11.    Recommendation

11.1.    Market Strategy

12.    Competitive Landscape

12.1.    Competition Dashboard

12.2.    List and Company Overview of Global Key Players

12.3.    Company Profiles

12.3.1.    Medtronic Plc.

12.3.1.1.    Company Overview

12.3.1.2.    Financial Overview

12.3.1.3.    Component Portfolio

12.3.1.4.    Key Developments

12.3.1.5.    Business Strategies

12.3.2.    Codman & Shurtleff, Inc.

12.3.3.    Raumedic AG

12.3.4.    Sophysa Ltd.

12.3.5.    MicroPort Scientific Corporation

12.3.6.    Orsan Medical Technologies

12.3.7.    Spiegelberg GmbH

13.    Acronyms

Select License Type

Frequently Asked Questions

The global unruptured intracranial aneurysm treatment market in 2020 is estimated for more than US$ 1,027.1 Mn and expected to reach a value of US$ 1,937.4 Mn by 2028 with a significant CAGR of 8.3%.

Increasing healthcare funding by government bodies, high occurrence of high blood pressure in the individuals, and advancement in surgical techniques and development of new drugs are the key factors driving the growth of market

Treatment method and region are the segments which are covered in market report

Some of the key participating players in global unruptured intracranial aneurysm treatment market is Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, and Spiegelberg GmbH.



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK